Shares of Vera Therapeutics, Inc. (VERA) have gained 1.7% over the past four weeks to close the last trading session at $49.1, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of$75.15 indicates a potential upside of 53.1%.The average comprises 13 short-term price targets ranging from a low of $33.00 to a high of$100.00, with a standard deviation of $19.54. While the lowest estima ...